Cargando…
Enfermedad de kawasaki
Kawasaki disease is a systemic vasculitis of unknow etiology that occurs predominantly in children under the age of 5 years. Kawasaki disease is the most common cause of acquired heart disease in children in the developed world. The exact cause has not yet been established but there is considerable...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedad Española de Reumatología. Published by Elsevier España S.L.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147879/ http://dx.doi.org/10.1016/S1577-3566(06)75082-5 |
_version_ | 1783520496143302656 |
---|---|
author | del Castillo Martín, Fernando |
author_facet | del Castillo Martín, Fernando |
author_sort | del Castillo Martín, Fernando |
collection | PubMed |
description | Kawasaki disease is a systemic vasculitis of unknow etiology that occurs predominantly in children under the age of 5 years. Kawasaki disease is the most common cause of acquired heart disease in children in the developed world. The exact cause has not yet been established but there is considerable support for it to be due to an infectious agent. The diagnosis of Kawasaki disease is based in clinical criteria: fever persisting at least 5 days and the presence of at least 4 principal features: changes of extremities, polymorphous exanthem, bilateral bulbar conjunctival injection without exudate, changes in lips and oral cavity and cervical lymphadenopathy > 1.5 cm, usually unilateral. The most common complication is coronary arterial aneurysm and coronay arterial dilatation that occurs in 20-25% untreated children. Standard treatment for Kawasaki disease include intravenous immunoglobulin as a single 2 g/kg dose within the first 10 days and oral acetilsalycilic acid. The risk of coronary damage in treated patient is 3-5%. |
format | Online Article Text |
id | pubmed-7147879 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Sociedad Española de Reumatología. Published by Elsevier España S.L. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71478792020-04-13 Enfermedad de kawasaki del Castillo Martín, Fernando Seminarios de la Fundación Española de Reumatología Article Kawasaki disease is a systemic vasculitis of unknow etiology that occurs predominantly in children under the age of 5 years. Kawasaki disease is the most common cause of acquired heart disease in children in the developed world. The exact cause has not yet been established but there is considerable support for it to be due to an infectious agent. The diagnosis of Kawasaki disease is based in clinical criteria: fever persisting at least 5 days and the presence of at least 4 principal features: changes of extremities, polymorphous exanthem, bilateral bulbar conjunctival injection without exudate, changes in lips and oral cavity and cervical lymphadenopathy > 1.5 cm, usually unilateral. The most common complication is coronary arterial aneurysm and coronay arterial dilatation that occurs in 20-25% untreated children. Standard treatment for Kawasaki disease include intravenous immunoglobulin as a single 2 g/kg dose within the first 10 days and oral acetilsalycilic acid. The risk of coronary damage in treated patient is 3-5%. Sociedad Española de Reumatología. Published by Elsevier España S.L. 2006-06 2009-01-06 /pmc/articles/PMC7147879/ http://dx.doi.org/10.1016/S1577-3566(06)75082-5 Text en Copyright © 2006 Sociedad Española de Reumatología. Published by Elsevier España S.L. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article del Castillo Martín, Fernando Enfermedad de kawasaki |
title | Enfermedad de kawasaki |
title_full | Enfermedad de kawasaki |
title_fullStr | Enfermedad de kawasaki |
title_full_unstemmed | Enfermedad de kawasaki |
title_short | Enfermedad de kawasaki |
title_sort | enfermedad de kawasaki |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147879/ http://dx.doi.org/10.1016/S1577-3566(06)75082-5 |
work_keys_str_mv | AT delcastillomartinfernando enfermedaddekawasaki |